Reliance Life Sciences Private Limited
Indian Pharmaceutical Exporter ยท Advanced Oncology Specialist ยท $42.3M Total Trade ยท DGFT Verified
Reliance Life Sciences Private Limited is an Indian pharmaceutical exporter with a total trade value of $42.3M across 14 products in 4 therapeutic categories. Based on 1,161 verified export shipments from Indian Customs (DGFT) records, Reliance Life Sciences Private Limited is the #1 Indian exporter in 2 products including Immunoglobulin, Adalimumab. Top exports include Immunoglobulin ($15.2M), Lenalidomide ($8.3M), Rituximab ($4.1M).
Reliance Life Sciences Private Limited โ Export Portfolio & Destination Treemap

Who is Reliance Life Sciences Private Limited? โ Company Overview & Market Position
Reliance Life Sciences Private Limited, established on January 30, 2001, is a prominent Indian pharmaceutical exporter headquartered in Navi Mumbai, Maharashtra. The company operates under the Corporate Identification Number (CIN) U24239MH2001PTC130654 and is classified as a private limited company. As of the latest available data, Reliance Life Sciences has an authorized capital of โน126.01 crore and a paid-up capital of โน96.01 crore. The company employs approximately 1,543 professionals, reflecting its substantial workforce dedicated to various facets of the pharmaceutical industry.
Reliance Life Sciences is a subsidiary of Reliance Industries Limited, a conglomerate with diversified interests across sectors such as petrochemicals, refining, and telecommunications. This affiliation provides Reliance Life Sciences with robust financial backing and access to a vast network, facilitating its operations in the pharmaceutical sector. The company's primary focus encompasses bio-therapeutics, pharmaceuticals, clinical research services, regenerative medicine, and molecular medicine. Notably, Reliance Life Sciences has launched five of the world's first biosimilars and holds the distinction of being the first integrated manufacturer of plasma proteins in South Asia.